You are viewing an incomplete version of our website. Please click to reload the website as full version.
24th- 25th September 2012, Copthorne Tara Hotel, London

Conference: SMi present their 3rd annual Biosimilars and Biobetters conference

Join SMi at their third Biosimilars and Biobetters conference that will discuss the impact of these new regulatory guidelines and their effects on approval of follow on biologics at this exciting event.
Join SMi at their third Biosimilars and Biobetters conference that will discuss the impact of these new regulatory guidelines and their effects on approval of follow on biologics at this exciting event. There will also be discussions on the rising development cost of biosimilars and marketing and pricing strategies, with a focus on case studies from those who are both developing and distributing follow on biologics. You cannot afford to miss this event. Key Benefits of Attending: • Be informed of the latest news in biosimilar pipelines • Evaluate current and future developments in intellectual property and patent protection • Discuss the impact of recent guidelines issued by regulatory bodies such as the FDA and EMEA • Asses commercial and financial strategies • Consider market access pathways and strategies • Develop plans and methods for biosimilar and biobetter drug design and clinical testing For more information contact Fateja Begum on fbegum@smi-online.co.uk or visit http://www.smi-online.co.uk/goto/biosimilars-biobetters15.asp